These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 6092681)

  • 1. Characterization and myocarditic capabilities of coxsackievirus B3 variants in selected mouse strains.
    Gauntt CJ; Gomez PT; Duffey PS; Grant JA; Trent DW; Witherspoon SM; Paque RE
    J Virol; 1984 Nov; 52(2):598-605. PubMed ID: 6092681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3.
    Knowlton KU; Jeon ES; Berkley N; Wessely R; Huber S
    J Virol; 1996 Nov; 70(11):7811-8. PubMed ID: 8892902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Properties of coxsackievirus B3 variants which are amyocarditic or myocarditic for mice.
    Gauntt CJ; Trousdale MD; LaBadie DR; Paque RE; Nealon T
    J Med Virol; 1979; 3(3):207-20. PubMed ID: 225441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic determinants of cardiovirulence in coxsackievirus B3 clinical isolates: localization to the 5' nontranslated region.
    Dunn JJ; Chapman NM; Tracy S; Romero JR
    J Virol; 2000 May; 74(10):4787-94. PubMed ID: 10775617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of myocarditic variants of Coxsackievirus B3 in inbred mice. A pathologic characterization of heart tissue damage.
    Chow LH; Gauntt CJ; McManus BM
    Lab Invest; 1991 Jan; 64(1):55-64. PubMed ID: 1990209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular immune responses in mice challenged with an amyocarditic variant of Coxsackievirus B3.
    Lutton CW; Gudvangen RJ; Nealon TJ; Paque RE; Gauntt CJ
    J Med Virol; 1985 Dec; 17(4):345-57. PubMed ID: 3001222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coxsackievirus-induced chronic myocarditis in murine models.
    Gauntt CJ; Tracy SM; Chapman N; Wood HJ; Kolbeck PC; Karaganis AG; Winfrey CL; Cunningham MW
    Eur Heart J; 1995 Dec; 16 Suppl O():56-8. PubMed ID: 8682103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential behaviour in pancreas and heart of two coxsackievirus B3 variants.
    Gómez RM; Cui X; Castagnino CG; Berría MI
    Intervirology; 1993; 36(3):153-60. PubMed ID: 8150596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T lymphocyte responses in CVB3-induced murine myocarditis.
    Huber S; Polgar J; Moraska A; Cunningham M; Schwimmbeck P; Schultheiss P
    Scand J Infect Dis Suppl; 1993; 88():67-78. PubMed ID: 7685923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistence of replicating coxsackievirus B3 in the athymic murine heart is associated with development of myocarditic lesions.
    Sato S; Tsutsumi R; Burke A; Carlson G; Porro V; Seko Y; Okumura K; Kawana R; Virmani R
    J Gen Virol; 1994 Nov; 75 ( Pt 11)():2911-24. PubMed ID: 7964602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mimicry, anti-coxsackievirus B3 neutralizing monoclonal antibodies, and myocarditis.
    Gauntt CJ; Arizpe HM; Higdon AL; Wood HJ; Bowers DF; Rozek MM; Crawley R
    J Immunol; 1995 Mar; 154(6):2983-95. PubMed ID: 7533190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coxsackievirus B3-induced myocarditis. Characterization of stable attenuated variants that protect against infection with the cardiovirulent wild-type strain.
    Zhang H; Morgan-Capner P; Latif N; Pandolfino YA; Fan W; Dunn MJ; Archard LC
    Am J Pathol; 1997 Jun; 150(6):2197-207. PubMed ID: 9176409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differing cardiotropic and myocarditic properties of group B type 4 coxsackievirus strains.
    Cao Y; Schnurr DP; Schmidt NJ
    Arch Virol; 1984; 80(2-3):119-30. PubMed ID: 6326709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The viral genetic background determines the outcome of coxsackievirus B3 infection in outbred NMRI mice.
    Schmidtke M; Merkle I; Klingel K; Hammerschmidt E; Zautner AE; Wutzler P
    J Med Virol; 2007 Sep; 79(9):1334-42. PubMed ID: 17607777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of an infectious cDNA of a highly cardiovirulent coxsackievirus B3(CVB3m) and comparison to other infectious CVB3 cDNAs.
    Lee C; Maull E; Chapman N; Tracy S; Wood J; Gauntt C
    Virus Res; 1997 Aug; 50(2):225-35. PubMed ID: 9282787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic detection of enteroviruses in the myocardium--studies on animal hearts with coxsackievirus B3 myocarditis and endomyocardial biopsies from patients with myocarditis and dilated cardiomyopathy.
    Koide H; Kitaura Y; Deguchi H; Ukimura A; Kawamura K; Hirai K
    Jpn Circ J; 1992 Oct; 56(10):1081-93. PubMed ID: 1331557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a murine model of myocarditis induced by a reactivated coxsackievirus B3.
    Zhang H; Yousef GE; Ouyang X; Archard LC
    Int J Exp Pathol; 1994 Apr; 75(2):99-110. PubMed ID: 8199011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Murine natural killer cells limit coxsackievirus B3 replication.
    Godeny EK; Gauntt CJ
    J Immunol; 1987 Aug; 139(3):913-8. PubMed ID: 3036947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased virulence of a human enterovirus (coxsackievirus B3) in selenium-deficient mice.
    Beck MA; Kolbeck PC; Shi Q; Rohr LH; Morris VC; Levander OA
    J Infect Dis; 1994 Aug; 170(2):351-7. PubMed ID: 8035022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic regions of coxsackievirus B3 associated with cardiovirulence.
    Lee C; Maull E; Chapman N; Tracy S; Gauntt C
    J Med Virol; 1997 Jul; 52(3):341-7. PubMed ID: 9210047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.